TGF-β induced by interleukin-34-stimulated microglia regulates microglial proliferation and attenuates oligomeric amyloid β neurotoxicity

Neuroscience Letters

Volumn 529, Issue 1, 2012, Pages 86-91

  Ma, Di ^a   Doi, Yukiko ^a   Jin, Shijie ^a   Li, Endong ^a   Sonobe, Yoshifumi ^a   Takeuchi, Hideyuki ^a   Mizuno, Tetsuya ^a   Suzumura, Akio ^a  

^a NAGOYA UNIVERSITY   (Japan)

Author keywords

IL 34; Microglia; Neuroprotection; Oligomeric amyloid ; TGF

Indexed keywords

2 (5 CHLORO 2 FLUOROPHENYL) 4 (4 PYRIDINYLAMINO)PTERIDINE; AMYLOID BETA PROTEIN; CYTOKINE; INTERLEUKIN 34; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; MICROGLIA; MOUSE; NERVE CELL CULTURE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION;

AMYLOID BETA-PEPTIDES; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; INTERLEUKINS; MICE; MICROGLIA; NEUROTOXINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84867694565     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.08.071     Document Type: Article

References (19)

1. Banno M., Mizuno T., Kato H., Zhang G., Kawanokuchi J., Wang J., Kuno R., Jin S., Takeuchi H., Suzumura A. The radical scavenger edaravone prevents oxidative neurotoxicity induced by peroxynitrite and activated microglia. Neuropharmacology 2005, 48:283-290.
2. Caraci F., Spampinato S., Sortino M.A., Bosco P., Battaglia G., Bruno V., Drago F., Nicoletti F., Copani A. Dysfunction of TGF-β1 signaling in Alzheimer's disease: perspectives for neuroprotection. Cell and Tissue Research 2012, 347:291-301.
3. Dahlgren K., Manelli A.M., W.B.Stine, Baker L.K., Krafft G.A., LaDu M.J. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. Journal of Biological Chemistry 2002, 277:32046-32053.
4. Demuro A., Mina E., Kayed R., Milton S.C., Parker I., Glabe C. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. Journal of Biological Chemistry 2005, 280:17294-17300.
5. Doi Y., Mizuno T., Maki Y., Jin S., Mizoguchi H., Ikeyama M., Doi M., Michikawa M., Takeuchi H., Suzumura A. Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid β neurotoxicity in in vitro and in vivo models of Alzheimer's disease. American Journal of Pathology 2009, 175:2121-2132.
6. Flanders K.C., Ren R.F., Lippa C.F. Transforming growth factor-βs in neurodegenerative disease. Progress in Neurobiology 1998, 54:71-85.
7. Li S., Hong S., Shepardson N.E., Walsh D.M., Shankar G.M., Selkoe D.J. Soluble oligomers of amyloid beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron 2009, 62:788-801.
8. Lin H., Lee E., Hestir K., Leo C., Huang M., Bosch E., Halenbeck R., Wu G., Zhou A., Behrens D., Hollenbaugh D., Linnemann T., Qin M., Wong J., Chu K., Doberstein S.K., Williams L.T. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 2008, 320:807-811.
9. McGeer P.L., McGeer E.G. Inflammation, autotoxicity and Alzheimer disease. Neurobiology of Aging 2001, 22:799-809.
10. Meda L., Cassatella M.A., Szendrei G.I., Otvos L., Baron P., Villalba M., Ferrari D., Rossi F. Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature 1995, 374:647-650.
11. Mizuno T., Doi Y., Mizoguchi H., Jin S., Noda M., Sonobe Y., Takeuchi H., Suzumura A. Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-β neurotoxicity. American Journal of Pathology 2011, 179:2016-2027.
12. Richard L., Filali M., Préfontaine P., Rivest S. Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease. Journal of Neuroscience 2008, 28:5784-5793.
13. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 2002, 298:789-791.
14. Shankar G.M., Bloodgood B.L., Townsend M., Walsh D.M., Selkoe D.J., Sabatini B.L. Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. Journal of Neuroscience 2007, 27:2866-2875.
15. Suzumura A., Mezitis S.G., Gonatas N.K., Silberberg D.H. MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: induction of Ia antigen expression by gamma-interferon. Journal of Neuroimmunology 1987, 15:263-278.
16. Suzumura A., Sawada M., Yamamoto H., Marunouchi T. Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. Journal of Immunology 1993, 151:2150-2158.
17. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 2002, 416:535-539.
18. Wyss-Coray T. Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer's. Current Alzheimers Research 2006, 3:191-195.
19. Yan P., Hu X., Song H., Yin K., Bateman R.J., Cirrito J.R., Xiao Q., Hsu F.F., Turk J.W., Xu J., Hsu C.Y., Holtzman D.M., Lee J.M. Matrix metalloproteinase-9 degrades amyloid-β fibrils in vitro and compact plaques in situ. Journal of Biological Chemistry 2006, 281:24566-24574.